SCHEDULE 13G Filed 2026-06-09 Event — SEC 0001440771-26-000004 →

Stonepine Capital Management, LLC → SINTX Technologies, Inc. SINT

Stake: — Shares: — Class: Common Stock

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 17/100

Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d

Passive Schedule 13G filer baseline
Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d
Short interest building (+36.8% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.06

136,441 shares short · +36.8% vs prior

Other 13D/G Filings on SINTX Technologies, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-09	SCHEDULE 13G	LYTTON LAURENCE W	—	—	view →
2020-06-22	SC	Binsalamah Ziyad	—	—	view →
2018-01-08	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by Stonepine Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-31	SCHEDULE 13G	Femasys Inc	—	—	view →
2026-08-26	SCHEDULE 13G	Edesa Biotech, Inc.	—	—	view →
2026-08-25	SCHEDULE 13G	CalciMedica, Inc.	—	—	view →
2026-07-21	SCHEDULE 13G	AEON Biopharma, Inc.	—	—	view →
2026-06-23	SCHEDULE 13G	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-06-22	SCHEDULE 13G	Azitra, Inc. AZTR	—	—	view →
2026-06-16	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →
2019-07-23	SC	VIVEVE MEDICAL, INC.	—	—	view →
2018-02-12	SC	VIVEVE MEDICAL, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →